FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer

[cafead]

via The US Food and Drug Administration (FDA) has placed a partial hold on three of the clinical studies of Zentalis Pharmaceuticals’ azenosertib, aimed at treating different types of cancer.

article source